Human Alpha-Fetoprotein: Immunosuppressive Activity and Microheterogeneity
- 1 January 1978
- journal article
- research article
- Published by Taylor & Francis in Immunological Communications
- Vol. 7 (2), 137-161
- https://doi.org/10.3109/08820137809033881
Abstract
Purified human alpha-fetoprotein (HAFP) from five patients with hepa-toma, one with gastric carcinoma, one with an embryonal cell tumor, and from fetal liver has demonstrated immnunosuppressive potencies in vitro which vary over three orders of magnitude. A reversible association of HAFP with the cell surface and a predominant effect on T cells are suggested. No evidence of complex fornation between HAFP and mitogen has been found. The microheterogeneity of HAFP has been detailed with crossed immunoelectrophoresis and isoelectric focusing in polyacrylamide gels containing 8M urea, and the immunosuppressive potency of HAFP isolated from a given source can be correlated with the proportion of certain HAFP species contained in it.This publication has 36 references indexed in Scilit:
- α-Fetoprotein induces suppressor T cells in vitroNature, 1977
- Suppression of the primary cell-mediated immune response by human α1-fetoprotein in vitroCellular Immunology, 1977
- Immunosuppression by mouse sialylated α-foetoproteinNature, 1977
- E rosette formation in the presence of α-fetoprotein and ferritinClinical Immunology and Immunopathology, 1976
- On soluble mediators of immunologic regulationCellular Immunology, 1976
- Inhibition of sensitization of T-cells by alpha-fetoproteinInternational Journal of Cancer, 1975
- Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.The Journal of Experimental Medicine, 1975
- Fetuin, an inhibitor of lymphocyte transformation. The interaction of fetuin with phytomitogens and a possible role for fetuin in fetal development.The Journal of Experimental Medicine, 1975
- ISOELECTRIC FOCUSING OF HUMAN α‐FETOPROTEIN: AN AID IN PURIFICATION AND CHARACTERIZATION OF MICROHETEROGENEITYAnnals of the New York Academy of Sciences, 1973
- SERUM-ALPHA-FETOPROTEIN LEVELS IN PATIENTS WITH ATAXIA-TELANGIECTASIAThe Lancet, 1972